openPR Logo
Press release

Chronic Plaque Psoriasis Therapeutics Market: Industry Analysis, Growth, Trends and Forecast 2017 – 2025

02-28-2018 12:40 PM CET | Health & Medicine

Press release from: Persistence Market Research

Chronic Plaque Psoriasis Therapeutics Market: Industry

Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/21442

Increasing uptake of biological drugs is one of the major factor propelling the growth of the global chronic plaque psoriasis therapeutics market. Advances in inflammation and immunology research, introduction of innovative drugs and increased focus on the usage of combination therapies are further accentuating the demand for chronic plaque psoriasis drugs. Adverse side effects, however, side-effects associated with the treatment such as risk of skin cancer, headache, hair loss, suppression of immunity and others could pose a major threat to the global chronic plaque psoriasis therapeutics market. Ixekizumab, tofacitinib, baricitinib, tregalizumab, ponesimod, AbGn-168H, E-6201, briakinumab, adalimumab and others are some of the drugs currently in clinical trials for the treatment of chronic plaque psoriasis.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/21442

Geographically, North America forms the largest regional market for chronic plaque psoriasis therapeutics. In addition, developed countries such as Germany, France, Spain, Italy, the U.K and Japan accounts for the second largest share of the global chronic plaque psoriasis therapeutics market due to emergence of new formulations.

The key manufacturers engaged in developing the chronic plaque psoriasis therapeutics market include Abbvie, Inc., Novartis International AG, Pfizer, Inc., Merck & Co., Astelllas Pharma, Inc., GlaxoSmithKline Plc and others.

Need more information about Report methodology ? @ https://www.persistencemarketresearch.com/methodology/21442

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Plaque Psoriasis Therapeutics Market: Industry Analysis, Growth, Trends and Forecast 2017 – 2025 here

News-ID: 961037 • Views:

More Releases from Persistence Market Research

Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by 2032
Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by …
Overview of the Market The Pedestrian Entrance Control Systems (PECS) market is poised for substantial growth over the coming years, driven by the increasing demand for secure and efficient access management solutions in commercial, residential, and industrial sectors. These systems are critical for controlling pedestrian flow while ensuring safety and compliance with security protocols. The market is witnessing rapid adoption due to rising urbanization, advancements in biometric and smart access technologies,
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Overview of the Digital Signature Market The global digital signature market is poised for remarkable growth, estimated to increase from US$ 8.4 billion in 2025 to US$ 38.5 billion by 2032, reflecting a robust CAGR of 25.8% during the forecast period. This surge is driven by the escalating demand for secure and efficient digital transaction solutions across industries such as BFSI, healthcare, government, and IT. Organizations are increasingly embracing digital signatures
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 2032
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 20 …
Overview of the Market The global family/indoor entertainment centers market is experiencing remarkable growth, fueled by increasing consumer demand for recreational and leisure activities. Estimated at US$ 46.8 billion in 2025, the market is projected to nearly double, reaching US$ 102.8 billion by 2032, registering a robust CAGR of 11.9% during the forecast period. Families and young adults are increasingly seeking immersive and interactive entertainment experiences, driving the popularity of indoor
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Persistence Market Research
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Pe …
Overview of the Market The global 5G network equipment market is set to experience exponential growth, with its size projected to rise from US$ 26,370.5 million in 2025 to US$ 101,824.3 million by 2032, reflecting a robust CAGR of 21.3% during the forecast period. The increasing need for ultra-fast wireless communication, low latency, and high network efficiency is driving the demand for 5G network infrastructure worldwide. Mobile operators and enterprises are

All 5 Releases


More Releases for Psoriasis

Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual
Psoriasis Vulgaris Market
Introduction Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome. The global psoriasis vulgaris
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Psoriasis Market Size During the Forecast Period? The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally. Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It